News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bristol-Myers Squibb Company (BMY) to Keep a Seattle Presence; to Preserve About 275 ZymoGenetics, Inc. (ZGEN) Jobs


1/26/2011 6:48:15 AM

Seattle Times -- Bristol-Myers Squibb, which bought Seattle drugmaker ZymoGenetics last year, plans to keep a long-term presence in Seattle's South Lake Union district, a spokeswoman said late Tuesday.

Read at Seattle Times
Read at Xconomy


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES